The US Fluorescent Immunoassay Market holds a significant share of the global industry, driven by the country's advanced healthcare infrastructure, strong presence of leading diagnostic companies, and increasing demand for rapid and accurate diagnostic testing. The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and diabetes has accelerated the adoption of...